Michael J. Ross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael J. Ross has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Paul E. Klotman
Mount Sinai School of Medicine, Division of Nephrology, Box 1243, 1 Gustave L Levy Place, New York, New York 10029,1 Mount Sinai School of Medicine, Division of Infectious Diseases, Box 1090, 1 Gustave L Levy Place, New York, New York 100292
6 shared publicationsAlexandra Snyder
Department of Nephrology, Mount Sinai School of Medicine, New York, New York 10029, USA
3 shared publicationsMary E. Klotman
Mount Sinai School of Medicine, Division of Nephrology, Box 1243, 1 Gustave L Levy Place, New York, New York 10029,1 Mount Sinai School of Medicine, Division of Infectious Diseases, Box 1090, 1 Gustave L Levy Place, New York, New York 100292
3 shared publicationsPengfei Gong
Department of Nephrology, Mount Sinai School of Medicine, New York, USA
3 shared publicationsLewis Kaufman
2 shared publicationsMichael J. Ross
Division of Nephrology, Mount Sinai School of Medicine, New York, NY 10029, USA
2 shared publications
Latest Publications
- 1 June 2017
- Published by Elsevier in Kidney International
- Vol. 91 (6) , 1269-1271
ACE2 as therapy for glomerular disease: the devil is in the detail
- 1 June 2017
- Published by Elsevier in Kidney International
- Vol. 91 (6) , 1269-1271
ACE2 as therapy for glomerular disease: the devil is in the detail
- 1 February 2016
- Published by Elsevier in Kidney International
- Vol. 89 (2) , 263-266
Epithelial-to-mesenchymal transition of tubular epithelial cells in renal fibrosis: a new twist on an old tale
- 1 February 2016
- Published by Elsevier in Kidney International
- Vol. 89 (2) , 263-266
Epithelial-to-mesenchymal transition of tubular epithelial cells in renal fibrosis: a new twist on an old tale
- 1 January 2015
- Published by Elsevier in Kidney International
- Vol. 87 (1) , 5-7
Minimizing risks associated with renal replacement therapy in patients with Ebola virus disease
- 1 January 2015
- Published by Elsevier in Kidney International
- Vol. 87 (1) , 5-7
Minimizing risks associated with renal replacement therapy in patients with Ebola virus disease
- 1 August 2014
- Published by Elsevier in Kidney International
- Vol. 86 (2) , 266-274
Advances in the pathogenesis of HIV-associated kidney diseases
- 1 August 2014
- Published by Elsevier in Kidney International
- Vol. 86 (2) , 266-274
Advances in the pathogenesis of HIV-associated kidney diseases
- Open Access
- 25 March 2014
- Published by Springer Nature in BMC Nephrology
- Vol. 15 (1) , 51
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study
No consensus exists on how to define abnormally rapid deterioration in renal function (Rapid Progression, RP). We developed an operational definition of RP in HIV-positive persons with baseline estimated glomerular filtration rate (eGFR) >90 ml/min/1.73 m2 (using Cockcroft Gault) in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study from 2004 to 2011.
- 25 March 2014
- Published by Springer Nature in BMC Nephrology
- Vol. 15 (1) , 51
Open AccessDevelopment of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study
No consensus exists on how to define abnormally rapid deterioration in renal function (Rapid Progression, RP). We developed an operational definition of RP in HIV-positive persons with baseline estimated glomerular filtration rate (eGFR) >90 ml/min/1.73 m2 (using Cockcroft Gault) in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study from 2004 to 2011.
- 21 January 2011
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 12 (5) , 691-704
Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients
(2011). Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients. Expert Opinion on Pharmacotherapy: Vol. 12, No. 5, pp. 691-704.
- 21 January 2011
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 12 (5) , 691-704
Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients
(2011). Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients. Expert Opinion on Pharmacotherapy: Vol. 12, No. 5, pp. 691-704.
- 15 May 2010
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (8) , 1107-1119
HIV-1 viral protein r induces ERK and caspase-8-dependent apoptosis in renal tubular epithelial cells
Objective: HIV-associated nephropathy (HIVAN) is the most common cause of end-stage renal disease in persons with HIV/AIDS and is characterized by focal glomerulosclerosis and dysregulated renal tubular epithelial cell (RTEC) proliferation and apoptosis. HIV-1 viral protein r (Vpr) has been implicated in HIV-induced RTEC apoptosis but the mechanisms of Vpr-induced RTEC apoptosis are unknown. The aim of this study was therefore to determine the mechanisms of Vpr-induced apoptosis in RTEC. Methods: Apoptosis and caspase activation were analyzed in human RTEC (HK2) after transduction with Vpr-expressing and control lentiviral vectors. Bax and BID were inhibited with lentiviral shRNA, and ERK activation was blocked with the MEK1,2 inhibitor, U0126. Results: Vpr induced apoptosis as indicated by caspase 3/7 activation, PARP-1 cleavage and mitochondrial injury. Vpr activated both caspases-8 and 9. Inhibition of Bax reduced Vpr-induced apoptosis, as reported in other cell types. Additionally, Vpr-induced cleavage of BID to tBID and suppression of BID expression prevented Vpr-induced apoptosis. Since sustained ERK activation can activate caspase-8 in some cell types, we studied the role of ERK in Vpr-induced caspase-8 activation. Vpr induced sustained ERK activation in HK2 cells and incubation with U0126 reduced Vpr-induced caspase-8 activation, BID cleavage and apoptosis. We detected phosphorylated ERK in RTEC in HIVAN biopsy specimens by immunohistochemistry. Conclusions: These studies delineate a novel pathway of Vpr-induced apoptosis in RTEC, which is mediated by sustained ERK activation, resulting in caspase 8-mediated cleavage of BID to tBID, thereby facilitating Bax-mediated mitochondrial injury and apoptosis.
- 15 May 2010
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (8) , 1107-1119
HIV-1 viral protein r induces ERK and caspase-8-dependent apoptosis in renal tubular epithelial cells
Objective: HIV-associated nephropathy (HIVAN) is the most common cause of end-stage renal disease in persons with HIV/AIDS and is characterized by focal glomerulosclerosis and dysregulated renal tubular epithelial cell (RTEC) proliferation and apoptosis. HIV-1 viral protein r (Vpr) has been implicated in HIV-induced RTEC apoptosis but the mechanisms of Vpr-induced RTEC apoptosis are unknown. The aim of this study was therefore to determine the mechanisms of Vpr-induced apoptosis in RTEC. Methods: Apoptosis and caspase activation were analyzed in human RTEC (HK2) after transduction with Vpr-expressing and control lentiviral vectors. Bax and BID were inhibited with lentiviral shRNA, and ERK activation was blocked with the MEK1,2 inhibitor, U0126. Results: Vpr induced apoptosis as indicated by caspase 3/7 activation, PARP-1 cleavage and mitochondrial injury. Vpr activated both caspases-8 and 9. Inhibition of Bax reduced Vpr-induced apoptosis, as reported in other cell types. Additionally, Vpr-induced cleavage of BID to tBID and suppression of BID expression prevented Vpr-induced apoptosis. Since sustained ERK activation can activate caspase-8 in some cell types, we studied the role of ERK in Vpr-induced caspase-8 activation. Vpr induced sustained ERK activation in HK2 cells and incubation with U0126 reduced Vpr-induced caspase-8 activation, BID cleavage and apoptosis. We detected phosphorylated ERK in RTEC in HIVAN biopsy specimens by immunohistochemistry. Conclusions: These studies delineate a novel pathway of Vpr-induced apoptosis in RTEC, which is mediated by sustained ERK activation, resulting in caspase 8-mediated cleavage of BID to tBID, thereby facilitating Bax-mediated mitochondrial injury and apoptosis.
- Open Access
- 1 February 2010
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 21 (2) , 316-326
The Ubiquitin-Like Protein FAT10 Mediates NF-κB Activation
NF-κB is a central mediator of innate immunity and contributes to the pathogenesis of several renal diseases. FAT10 is a TNF-α–inducible ubiquitin-like protein with a putative role in immune response, but whether FAT10 participates in TNF-α–induced NF-κB activation is unknown. Here, using renal tubular epithelial cells (RTECs) derived from FAT10−/− and FAT10+/+ mice, we observed that FAT10 deficiency abrogated TNF-α–induced NF-κB activation and reduced the induction of NF-κB–regulated genes. Despite normal IkBα degradation and polyubiquitination, FAT10 deficiency impaired TNF-α–induced IkBα degradation and nuclear translocation of p65 in RTECs, suggesting defective proteasomal degradation of polyubiquitinated IkBα. In addition, FAT10 deficiency reduced the expression of the proteasomal subunit low molecular mass polypeptide 2 (LMP2). Transduction of FAT10−/− RTECs with FAT10 restored LMP2 expression, TNF-α–induced IkBα degradation, p65 nuclear translocation, and NF-κB activation. Furthermore, LMP2 transfection restored IkBα degradation in FAT10−/− RTECs. In humans, common types of chronic kidney disease associated with tubulointerstitial upregulation of FAT10. These data suggest that FAT10 mediates NF-κB activation and may promote tubulointerstitial inflammation in chronic kidney diseases.
- 1 February 2010
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 21 (2) , 316-326
Open AccessThe Ubiquitin-Like Protein FAT10 Mediates NF-κB Activation
NF-κB is a central mediator of innate immunity and contributes to the pathogenesis of several renal diseases. FAT10 is a TNF-α–inducible ubiquitin-like protein with a putative role in immune response, but whether FAT10 participates in TNF-α–induced NF-κB activation is unknown. Here, using renal tubular epithelial cells (RTECs) derived from FAT10−/− and FAT10+/+ mice, we observed that FAT10 deficiency abrogated TNF-α–induced NF-κB activation and reduced the induction of NF-κB–regulated genes. Despite normal IkBα degradation and polyubiquitination, FAT10 deficiency impaired TNF-α–induced IkBα degradation and nuclear translocation of p65 in RTECs, suggesting defective proteasomal degradation of polyubiquitinated IkBα. In addition, FAT10 deficiency reduced the expression of the proteasomal subunit low molecular mass polypeptide 2 (LMP2). Transduction of FAT10−/− RTECs with FAT10 restored LMP2 expression, TNF-α–induced IkBα degradation, p65 nuclear translocation, and NF-κB activation. Furthermore, LMP2 transfection restored IkBα degradation in FAT10−/− RTECs. In humans, common types of chronic kidney disease associated with tubulointerstitial upregulation of FAT10. These data suggest that FAT10 mediates NF-κB activation and may promote tubulointerstitial inflammation in chronic kidney diseases.
- 15 November 2009
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (22) , 11983-11988
FAT10: a Novel Mediator of Vpr-Induced Apoptosis in Human Immunodeficiency Virus-Associated Nephropathy
Human immunodeficiency virus (HIV)-associated nephropathy is a significant cause of morbidity and mortality in HIV-infected persons. Vpr-induced cell cycle dysregulation and apoptosis of renal tubular epithelial cells are important components of the pathogenesis of HIV-associated nephropathy (HIVAN). FAT10 is a ubiquitin-like protein that is upregulated in renal tubular epithelial cells in HIVAN. In these studies, we report that Vpr induces increased expression of FAT10 in tubular cells and that inhibition of FAT10 expression prevents Vpr-induced apoptosis in human and murine tubular cells. Moreover, we found that Vpr interacts with FAT10 and that these proteins colocalize at mitochondria. These studies establish FAT10 as a novel mediator of Vpr-induced cell death.
- 15 November 2009
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (22) , 11983-11988
FAT10: a Novel Mediator of Vpr-Induced Apoptosis in Human Immunodeficiency Virus-Associated Nephropathy
Human immunodeficiency virus (HIV)-associated nephropathy is a significant cause of morbidity and mortality in HIV-infected persons. Vpr-induced cell cycle dysregulation and apoptosis of renal tubular epithelial cells are important components of the pathogenesis of HIV-associated nephropathy (HIVAN). FAT10 is a ubiquitin-like protein that is upregulated in renal tubular epithelial cells in HIVAN. In these studies, we report that Vpr induces increased expression of FAT10 in tubular cells and that inhibition of FAT10 expression prevents Vpr-induced apoptosis in human and murine tubular cells. Moreover, we found that Vpr interacts with FAT10 and that these proteins colocalize at mitochondria. These studies establish FAT10 as a novel mediator of Vpr-induced cell death.
- 1 May 2006
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 42 (1) , 1-11
HIV-1 Infection Initiates an Inflammatory Cascade in Human Renal Tubular Epithelial Cells
HIV-associated nephropathy (HIVAN) is the most common cause of chronic renal failure in HIV-infected patients. Tubulointerstitial inflammation is a prominent component of the histopathology of HIVAN. The pathogenesis of HIVAN is a result of infection of renal epithelial cells, but the cellular response to this infection remains poorly defined. In these studies, we used oligonucleotide microarrays to identify differentially expressed genes in renal tubular epithelial cells from a patient with HIVAN at three time points after infection with vesicular stomatitis virus-pseudotyped gag/pol-deleted HIV-1. Very few genes were differentially expressed 12 and 24 hours after infection. Three days after infection, however, 47 genes were upregulated by at least 1.8-fold. The most prominent response of these cells to HIV-1 expression was production of proinflammatory mediators, including chemokines, cytokines, and adhesion molecules. Many of the upregulated genes are targets of interleukin 6 and nuclear factor kappa B regulation, suggesting a central role for these proteins in the response of tubular epithelial cells to HIV-1 infection. Analysis of kidneys from HIV-1 transgenic mice revealed upregulation of many of the proinflammatory genes identified in the microarray studies. These studies provide novel insights into the mechanisms by which HIV-1 infection of tubular epithelial cells leads to tubulointerstitial inflammation and progressive renal injury.
- 1 May 2006
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 42 (1) , 1-11
HIV-1 Infection Initiates an Inflammatory Cascade in Human Renal Tubular Epithelial Cells
HIV-associated nephropathy (HIVAN) is the most common cause of chronic renal failure in HIV-infected patients. Tubulointerstitial inflammation is a prominent component of the histopathology of HIVAN. The pathogenesis of HIVAN is a result of infection of renal epithelial cells, but the cellular response to this infection remains poorly defined. In these studies, we used oligonucleotide microarrays to identify differentially expressed genes in renal tubular epithelial cells from a patient with HIVAN at three time points after infection with vesicular stomatitis virus-pseudotyped gag/pol-deleted HIV-1. Very few genes were differentially expressed 12 and 24 hours after infection. Three days after infection, however, 47 genes were upregulated by at least 1.8-fold. The most prominent response of these cells to HIV-1 expression was production of proinflammatory mediators, including chemokines, cytokines, and adhesion molecules. Many of the upregulated genes are targets of interleukin 6 and nuclear factor kappa B regulation, suggesting a central role for these proteins in the response of tubular epithelial cells to HIV-1 infection. Analysis of kidneys from HIV-1 transgenic mice revealed upregulation of many of the proinflammatory genes identified in the microarray studies. These studies provide novel insights into the mechanisms by which HIV-1 infection of tubular epithelial cells leads to tubulointerstitial inflammation and progressive renal injury.